About this trial
This study aimed to aim to investigate the efficacy of individualized rTMS according to lateralization index on motor recovery and cortical excitability in subacute stroke patients.
Eligibility criteria
Qualifiers
Unilateral ischemic or hemorrhagic stroke
Stroke within 3 months
Medical Research Council Scale for Muscle Strength in upper limb ≤ 3
No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases.
Disqualifiers
Previous stroke, traumatic brain injury, brain tumor
With central nervous system disease (spinal cord injury, Parkinson's disease)
Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker)
Patients unable to cooperate the treatment
Trial design
Treatments tested in this trial
- Repetitive transcranial magnetic stimulation
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.